Methods and compositions for modulating adipocyte function

Details Methods and compositions for modulating adipocyte function Methods and compositions for modulating adipocyte function

2004-10-18

2009-08-18

Kemmerer, Elizabeth C. (Department: 1646)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S007600, C514S008100, C514S012200

Reexamination Certificate

active

07576052

ABSTRACT:
Methods and compositions for treating obesity and related disorders. The methods include the use of BMP-2, -4, -6 and -7.

REFERENCES:
patent: 4997828 (1991-03-01), Kappas et al.
patent: 5187076 (1993-02-01), Wozney et al.
patent: 7355049 (2008-04-01), Chu et al.
patent: 2005/0272649 (2005-12-01), Hruska et al.
Asahina et al. (1996, Exp. Cell Res. 222:38-47).
Chen et al. (2001, J. Cell. Biochem. 82:187-199).
Science Daily, Apr. 8, 2005, “Study of Obese Diabetics Explains Why Low-carb Diets Produce Fast Results.” Accessed on Apr. 28, 2008 at www.sciencedaily.com/releases/2005/050326095632.htm.
Boden et al., “Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6,” Endocrinology 138(7):2820-8 (1997).
Celeste et al. “Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone,” Proc. Natl. Acad. Sci. USA 87(24):9843-7 (1990).
Chen et al., “Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precusor cells to osteoblast and adipocyte lineages,” J. Cell Biol. 142(1):295-305 (1998).
Dernyck et al., “Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells,” Nature 316(6030):701-5 (1985).
Einhorn, “Clinical applications of recombinant human BMPs: early experience and future development,” J. Bone Joint Surg. Am. 85-A Suppl 3:82-8 (2003).
Fasshauer et al., “Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes,” Mol. Cell Biol. 21(1):319-29 (2001).
Gentry et al., “Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide,” Mol. Cell Biol. 8(10):4162-8 (1988).
Gregoire et al., “Understanding adipocyte differentiation,” Physiol. Rev. 78(3):783-809 (1998).
Hamann et al., “Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat,” Diabetes 44(11):1266-73 (1995).
Hamann et al., “Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia,” Endocrinology 137(1):21-9 (1996).
Klein et al., “beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes,” J. Biol. Chem. 274(49):34795-802 (1999).
Lowell et al., “Development of obesity in transgenic mice after genetic ablation of brown adipose tissue,” Nature 366(6457):740-2 (1993).
MacDougald et al., “Adipogenesis: forces that tip the scales,” Trends Endocrinol. Metab. 13(1):5-11 (2002).
Paulik et al., “Thiazolidinediones inhibit alkaline phosphatase activity while increasing expression of uncoupling protein, deiodinase, and increasing mitochondrial mass in C3H10T½cells,” Cell Tissue Res. 290(1):79-87 (1997).
Puigserver et al., “A cold-inducible coactivator of nuclear receptors linked to adaptive thermogeneis,” Cell 92(6):829-39 (1998).
Sandhu, “Bone morphogenetic proteins and spinal surgery,” Spine 28(15 Suppl):S64-73 (2003).
Tamada et al., “Molecular cloning and analysis of the 5'-flanking region of the human bone morphogenetic protein-6 (BMP-6),” Biochim. Biophys. Acta. 1395(3):247-51 (1998).
Tang et al., “Commitment of C3H10T½pluripotent stem cells to the adipocyte lineage,” Proc. Natl. Acad. Sci. USA 101(26):9607-11 (2004).
Todaro and Green, “Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines,” J. Cell Biol. 17:299-313 (1963).
Tseng et al., “Differential roles of insulin receptor substrates in the anti-apoptotic function of insulin-like growth factor-1 and insulin,” J. Biol. Chem. 277(35):31601-11 (2002).
Tseng et al., “Differential roles of insulin receptor substrates in brown adipocyte differentiation,” Mol. Cell Biol. 24(5):1918-29 (2004).
Wozney et al., “Novel regulators of bone formation: molecular clones and activities,” Science 242(4885):1528-34 (1988).
Klaus et al., “Functional assessment of white and brown adipocyte development and energy metabolism in cell culture. Dissociation of terminal differentiation and thermogenesis in brown adipocytes,” J. Cell. Sci. 108:3171-3180 (1995).
UniProtKB Entry: P12644; Entry Name BMP4—HUMAN; Integrated into Swiss-Prot on Oct. 1, 1989.
UniProtKB Entry: P18075; Entry Name BMP7—HUMAN; Integrated into Swiss-Prot on Nov. 1, 1990.
UniProtKB Entry: P22003; Entry Name BMP5—HUMAN; Integrated into Swiss-Prot on Aug. 1, 1991.
UniProtKB Entry: P22004; Entry Name BMP6—HUMAN; Integrated into Swiss-Prot on Aug. 1, 1991.
UniProtKB Entry: P12643; Entry Name BMP2—HUMAN; Integrated into Swiss-Prot on Oct. 1, 1989.
Zhou et al., Cidea-deficient mice have lean phenotype and are resistant to obesity. Nature Genetics, 35:49-56, 2003.
Tvrdik et al., Cig30, a mouse member of a novel membrane protein gene family, is involved in the recruitment of brown adipose tissue. Jour. Biol. Chem., 272:31738 31746, 1997.
Leonard et al., Thyroxine 5'-deiodinase activity in brown adipose tissue. Endocrinology, 112:1153-1155, 1983, Abstract.

Affiliated with

Also associated with

Rating

Methods and compositions for modulating adipocyte function does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for modulating adipocyte function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for modulating adipocyte function will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4084607